Anti-Hepatitis a Virus Frequency in Adolescents at an Outpatient Clinic in so Paulo, Brazil
Posted on: Thursday, 16 March 2006, 09:01 CST
By Dinelli, Maria Isabel Saraiva; Fisberg, Mauro; de Moraes-Pinto, Maria Isabel
SUMMARY
The prevalence of hepatitis A virus (HAV) antibodies was assessed in adolescents (age ranging from 10.4 to 19.9 years) at an Adolescent Outpatient Clinic in So Paulo. Brazil. Anti-HAV was detected in 137 (54.2%) out of 253 individuals. When separated into two age groups. anti-HAV frequency was higher in the 15 to 19 year- old group (64%) in comparison to the 10 to 14 year-old group (46%) (Chi-square test: p = 0.004). These results suggest that adolescents in So Paulo are at risk of hepatitis A infection and arc probably contracting HAV infection during this age period.
KEYWORDS: Hepatitis A; Adolescents; Scroprcvalence; Brazil.
INTRODUCTION
The epidemiological pattern of hepatitis A virus (HAV) infection has been changing in Latin America in the last few years. Some countries shifted from high to intermediate rales of antibody seroprevalence12,13. Intermediate endemicity was also observed in the Northeastern. Southern and Southeastern regions of Brazil1. In So Paulo State there was an important decrease in antibody prevalence rate in the last two decades7,9, probably related to an improvement in socioeconomic conditions.
It is noteworthy that many Brazilian studies have shown an inverse relation between seroprevalence of HAV infection and socioeconomic and sanitary conditions1,4,6,9,10,11,14.
Periodic and updated seroprevalence studies are important tools to evaluate the susceptibility of a population to HAV infection and project Public Health policies.
MATERIAL AND METHODS
From May to the beginning October 2001, 253 adolescents (age ranging from 10.4 to 19.9 years, 63% male and 37% female) were assessed at the Adolescent Outpatient Clinic of the Federal University of So Paulo in So Paulo, Brazil. Around 240 adolescents attend the Clinic every month, and individuals come mainly from middle/low socioeconomic class.
Adolescents were invited to participate in this study and a questionnaire and blood sample were collected on the same day. Most new patients were included in the study and one in each four individuals already followed up at the Clinic was recruited. Information regarding home water supply and public sewerage service was obtained.
Qualitative determination of antibodies to hepatitis A virus (antiHAV) was performed using a competitive ELISA commercial kit (DiaSorin, Italy). The study was submitted to the Ethics Committee and svritten informed consent was obtained before enrolment.
RESULTS
The prevalence of anti-HAV in adolescents was 54.2% (137/253). When separated into two age groups, those from the 10 to 14 year- old group showed lower hepatitis A seroprevalence than those from the 15 to 19 year-old group (46% versus 65%, respectively; Chi- square test, p = 0.004).
Four individuals had previously received vaccine against hepatitis A and had anti-HAV antibodies. Eleven adolescents reported hepatitis A infection in the past and anti-HAV was detected in ten of them (90.9%).
Anti-HAV seropositivity was found in 132/246 (53.7%) of adolescents living in houses with public water supply, and in 5/7 (71.4%) without it. (Fisher's exact test, p = 0.46). Antibodies against HAV were present in 109/210 (51.9%) individuals living in houses with public sewerage service and in 28/43 (65.1%) of those without it (Chi-square test, p = 0.11).
DISCUSSION
In this study, 46.8% adolescents were susceptible to hepatitis A virus infection. This is especially worrying because the disease is frequently symptomatic in adolescents and adults, while hepatitis A infection in children is usually asymptomatic or has nonspecific manifestations2,3.
Lower anli-HAV seroprevalence rales were obtained in a previous study performed in So Paulo city including individuals from all socioeconomic levels: 36% and 56% among 10 to 14 year-old adolescents and 15 to 19 year-old ones, respectively7. This difference may be due Io the fact that the population in our study belonged to the middle/low socioeconomic group.
Anti-HAV seropositivity was higher in individuals living in houses without public water supply or sewerage service. However, that difference was not statistically significant probably because of the sample size.
As already shown in previous studies, our data points to a decrease in HAV seroprevalence in Brazil". However, the higher percentage of HAV seropositive individuals from 15 to 19 years in comparison to those from 10 to 14 years suggests that many individuals might be infected by hepatitis A virus during adolescence.
Besides improvement in education and sanitary conditions, immunization against hepatitis A could be a strategy to prevent infection. In regions of intermediate endemicity like the city of So Paulo, large-scale vaccination in childhood may be considered. Interestingly, a vaccination program with preadolescents in Catalonia, Spain, reduced the incidence of hepatitis A infection in all age groups below 60 years of age5,8.
RESUMO
Soroprevalncia de hepatite A cm adolescentes de ambulatrio em So Paulo, Brasil
A prevalncia de anticorpos contra o vrus da hepatite A foi avaliada em adolescentes de 10,4 a 19,9 anos alendidos no Ambulatorio de Adolescentes da Universidade Federal de So Paulo. Entre 253 indivduos analisados, a prevalncia de anticorpos foi de 54,2%. Quando os adolescentes forain separados em duas faixas etrias, a prevalncia foi maior no grupo de 15 a 19 anos (64%) em comparao com os de 10 a 14 anos (46%) (Qui-quadrado: p = 0,004). Estes resultados sugerem que muitos adolescentes de So Paulo esto sob risco de infeco pelo virus da hepatite A e alguns deles esto provavelmente se infectando durante a adolescncia.
ACKNOWLEDGEMENT
We thank "Fundo de Auxlio ao Docente e ao Aluno" (FADA) of the Federal University of So Paulo, for financial support.
REFERENCES
1. ALMEIDA, L.M.; WERNECK. G.L.; CAIRNCRUSS, S. et al. - The epidemiology of hepatitis A in Rio de Janeiro: environmental and domestic risk factors. Epidem. Infect., 127: 327-333, 2001.
2. AMERICAN ACADEMY OF PEDIATRICS - Hepatitis A. In: PICKERING, U.K., ed. Red hook. Report of the Committee on infectious diseases. 26 ed. Elk Grove Village. American Academy of Pediatrics, 2003. p. 309-310.
3. ARMSTRONG, G.L. & BELL, B.P. - Hepatitis A virus infection in the United States: model-based estimates and implications for childhood immunization. Pediatrics, 109: 839-R45, 2002.
4. CLEMENS, S.A.C.: FONSECA, J.C.; AZEVEDO, T. et al. - Soroprevalncia para hepatite A e B cm quatro centres no Brazil. Rev. Soc. bras. Med. trop.. 33: 1-10, 2000.
5. DOMINGUEZ, A.: SALLERAS, L.: CARMONA, G. & BATALLA. J. - Effectiveness of a mass hepatitis A vaccinalion program in preadolescents. Vaccine, 21: 698-701, 2003.
6. FERREIRA, C.T.; SILVA, G.L.; BARROS, F.C. & PEREIRA-LIMA, J. - Soroepidemiologia da hepatite A em dois grupos populacionais cconomicamente dislinlos de Porto Alegrc. GED, 5: 85-90, 1996.
7. FOCACCIA, R.; CONCEIO, O.J.G.; SETTE Jr., II. et al. - Estimated prevalence of viral hepatitis in the general population of the municipality of Sao Paulo, measured by a serologie survey of a stratified randomized and residence-based population. Braz. J. infect. Dis.. 2: 269-284, 1998.
8. LOPALCO, PL.: SARELLAS, L.; BARBUTI, S. et al. - Hepatitis A and B in children and adolescents: what can we learn from Puglia (Italy) and Catalonia (Spain). Vaccine, 19: 470-474, 2001.
9. PANNUTI, C.S.; MENDONCA, J.S.; CARVALHO. M.J.M.; OSELKA. G.W. & AMATO NETO, V. - Hepatitis A antibodies in two sociocconomically distinct populations of So Paulo. Brazil. Rev. Inst. Med. trop. S. Paulo, 27: 162-164, 1985.
10. PINHO, J.R.R.; SUMITA, L.M.; MOREIRA, R.C. el al. - Duality of patterns in hepatitis A epidemiology: a study involving two sociocconomieally distinct populations in Campinas, So Paulo State. Brazil. Rev. Inst. Med. trop. S. Paulo, 40: 105-106, 1998.
11. SABACK, F.L.; PALMER, T.E.: SABINO, R.R. et al. - Infection with hepatitis A and TT viruses and socioeconomic status in Rio de Janeiro, Brazil. Scand. J. infect. Dis.. 33: 121-125, 2001.
12. TANAKA, J. - Hepatitis A shifting epidemiology in Latin America. Vaccine, 18: S57-S60, 2000.
13. TAPIA-CONYER, R.; SANTOS. J.I.; CAVALCANTI. A.M. et al. - Hepatitis A in Latin America: a changing cpidcmiologic pattern. Amer. J. trop. Med. Hyg., 61: 825-829, 1999.
14. VITRAL, C.L.; YOSHIDA, C.F.T.; LEMOS. E.R.S.; TEIXEIRA,C.S. & CASPAR, A.M.C. - Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors. Mem. Inst. Oswaldo Cruz. 93: 1-5, 1998.
Received: 17 March 2005
Accepted: 29 September 2005
Maria Isabel Sarai>a DlNKLLI(1), Mauro FISIiKRGUl & Maria Isabel de MORAKS-PINTO(1)
(1) Department of Pediatrics, Division of Pediatric Infectious Diseuses. Federal University of Sn Paulo, So Paulo, Brazil.
(2) Department of Pediatrics, Adolescent Outpatient Clinic, Federal University of So Paulo, So Paulo, Brazil.
Correspondence to: Maria Isabel de Moraes-Pinto, Rua Pedro de Toledo 781, 9 undar, 04039-032 So Paulo, SP, Brazil. Phone: 55 11 5574.6471. e-mail: m.isabelinp@uol.com.br
Copyright Instituto de Medicina Tropical de Sao Paulo Jan/Feb 2006
Source: Revista do Instituto de Medicina Tropical de Sao Paulo
Related Articles
- Journal Cover Shows Cell Infected By Virus First Viewed By MSU Scientists
- IL-2 Immunotherapy Fails To Help HIV-Infected Individuals Already Taking Antiretrovirals
- Rapid Membrane Fusion of Individual Virus Particles With Supported Lipid Bilayers
- AVI BioPharma Announces Hepatitis C Virus Clinical Study Modification
- Celera Genomics and Specialty Laboratories Announce Licensing Agreement for Commercialization of Cirrhosis Testing; Genetic Testing Could Be a Better Predictor for High Risk HCV Infected Individuals Than Current Clinical Factors
- Dengue and West Nile Viruses Are Studied
- Most Internet Users Don't Know Their Computers Are Infected With Viruses and Spyware
- Microsoft Acquisition Adds to Anti-Virus, Anti-Spam Arsenal
- IL-7 is a Potent and Proviral Strain-Specific Inducer of Latent HIV- 1 Cellular Reservoirs of Infected Individuals on Virally Suppressive HAART
- Regional Differences in Emphysema Scores and BAL Glutathione Levels in HIV-Infected Individuals*
User Comments (0)

RSS Feeds